Rebozo and External Cephalic Version in Breech Presentation. (RECeiVe)

February 20, 2019 updated by: Jacob Alexander Lykke, Hvidovre University Hospital

Rebozo Som Vendingsmetode Ved sædepræsentation (in Danish)

Breech presentation occurs in approximately 3-5% of all pregnancies, and breech birth is more complicated and risky for the fetus than births of fetuses in the cephalic position.

Therefore, it is desirable to turn the fetus from breech presentation to cephalic position before labour. This is traditionally done by external cephalic version, where the doctor manually tries to turn the fetus; the success rate of this is approximately 50%, and complications occur in about 0.5%. In addition there is discomfort and pain to the pregnant woman.

The investigators will assess the effect of using the rebozo prior to the external version. Use of rebozo is a recognized technique from Mexico, where the midwife with a scarf 'shake' the pregnant woman's pelvis over several sessions, so the fetus spontaneously turns to cephalic presentation or the external version is facilitated.

There are no known complications associated with the rebozo method. Use of rebozo in breech presentation has never before been studied scientifically, but is used in many places in the world. The investigators are planning an open-labeled randomized controlled study in pregnancies with verified breech or transverse presentation: by lot either standard external cephalic version or preceding rebozo-treatment with subsequent external cephalic version.

The investigators want to assess whether the use of rebozo - either as pre-treatment for external cephalic version or as a catalyst of spontaneous version - will increase the incidence of the cephalic presentations at labour and thus reduce the number of planned caesarean section.

The population will be pregnant women with ultrasound verified breech or transverse presentation;all women who fulfill the local guideline criteria for external cephalic version, can be included. Exclusion criteria are non-Danish speaking or reading.

The recruitment will be conducted by midwife at week 35 in the antenatal care. The study design will be open-labeled randomized controlled. Randomisation is done by "closed envelope method" and stratified by parity. Intervention is rebozo exercises performed over 3-5 days from randomization. In case of persistent breech presentation, the woman is offered standard external cephalic version. The control group will also be offered external cephalic version after 3-5 days from randomization.

The investigators will use source data from existing local databases, "Obstetrics Database" and "version Database", for collecting birth outcome. In all stages of intervention documented electronically by project midwives.

The primary objective is the number of successful versions in total, i.e., after intervention and external cephalic version. We expect to increase the success rate from 50% to 65%, thus requiring 378 women in the study.

Secondary objectives are the number of successful vaginal births with birth in head position and total number of caesarean.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

370

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hvidovre
      • Copenhagen, Hvidovre, Denmark, 2650
        • Hvidovre Hospital, dept. of Obstetrics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Understands Danish in writing.
  • Intention of accepting vaginal delivery if cephalic presentation.
  • Can be offered standard treatment of external cephalic version according to local guidelines, e.g.:

    • Singleton pregnancy
    • Fetus in breech or transverse position
  • The gestational age at randomization must be between 35w+0/7d and 37w+4/7d so that the ECV is no later than 38w+0/7d for parous and 37w + 0/7d for nulliparous women.

Exclusion Criteria:

  • Women that cannot be offered external cephalic version according local guideline, e.g.:

    • placenta praevia and vasa praevia.
    • Suspicion of severe fetal growth restriction.
    • Severe preeclampsia.
    • Uterus anomalies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rebozo
Intervention by Rebozo
Shaking of the maternal pelvis by the midwife to increase the spontaneous cephalic version rate in breech presentation.
No Intervention: Control
Standard

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cephalic presentation
Time Frame: After external cephalic version
After external cephalic version

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Version rate by the intervention only
Time Frame: Before external cephalic version
Before external cephalic version
Version rate by the standard external cephalic version
Time Frame: At the external cephalic version
At the external cephalic version
Rate of cesarean section by intervention and presentation.
Time Frame: In labour
In labour
Dystocia in labor in cephalic presentation after version
Time Frame: In labour
Use of Pitocin, vacuum extraction and time frame.
In labour
Inducement of labour
Time Frame: Before labour
Before labour
Time frames for rupture of membranes, labour, first and second stage labour
Time Frame: In Labour
In Labour
Number of women having epidural
Time Frame: In labour
In labour
Fetal presentation, cephalic rotation and asynclitism
Time Frame: In labour
In labour
Vaginal and perineal ruptures after vaginal delivery
Time Frame: Hours after delivery
Hours after delivery
Neonatal outcome
Time Frame: Up to 28 days after delivery
Up to 28 days after delivery
Woman's experience of intervention and external cephalic version
Time Frame: After intervention, before labour or cesarean section.
After intervention, before labour or cesarean section.
Obstetrician's rating of difficulty in performing the external cephalic version
Time Frame: After intervention, before labour or cesarean section.
After intervention, before labour or cesarean section.
Major complications
Time Frame: During the study
Fetal demise, placental abruption, fetal distres (by CTG).
During the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jacob Alexander Lykke, MD PhD, Ass. prof., consultant

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2015

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

December 21, 2014

First Submitted That Met QC Criteria

January 3, 2015

First Posted (Estimate)

January 6, 2015

Study Record Updates

Last Update Posted (Actual)

February 22, 2019

Last Update Submitted That Met QC Criteria

February 20, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breech Presentation

Clinical Trials on Rebozo

Subscribe